Skip To The Main Content
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Vanessa K. Burrows
Counsel
 
900 G Street, NW
Washington, D.C. 20001 
 
Email:
Phone: +1-202-636-5891
Fax: +1-202-636-5502

With experience involving Food and Drug Administration (FDA) and other healthcare regulatory matters, Vanessa has advised pharmaceutical and medical device manufacturers, healthcare and technology companies, hospitals and other providers in connection with regulatory and compliance needs, as well as in connection with M&A and capital-raising transactions. Vanessa has extensive experience counseling clients with respect to Health Insurance Portability and Accountability Act (HIPAA) compliance, health privacy, security and breach issues, pharmacy law, cannabis and hemp laws, and public health matters. Vanessa is Counsel in our Washington, D.C. office.

Read Full Biography...

Work Highlights
  • Experience prior to Simpson Thacher includes advising:
    • Medical device manufacturers on FDA inspections, warning letters, import alerts and detentions, clinical trial regulations, communications regarding investigational and marketed devices, and product development, labeling and claims
    • Pharmaceutical manufacturers on off-label promotion, codes of conduct, gift and entertainment policies, drug shortages and patient assistance programs
    • Investors, advisors, consultants, hospital and health systems, and manufacturers on FDA, DOJ, DEA, USDA, and state laws, regulations and guidance on hemp, cannabidiol (CBD) and cannabis products
    • A multinational technology company and applicable manufacturers on the Open Payments provisions of the Patient Protection and Affordable Care Act, implementing federal regulations and state transparency and disclosure laws
    • Compounding pharmacies in connection with FDA and state inspections and laws related to dispensing and distribution 
    • Clients on anti-kickback, compliance, and scope of practice issues identified in the course of regulatory due diligence
Education
  • American University, Washington College of Law, 2006 J.D.
    cum laude
  • Queen’s University Belfast, 2002 M.A.
    with honors
  • Valparaiso University, 2001 B.A.
    magna cum laude
Associations
  • American Health Lawyers Association
  • Food and Drug Law Institute
  • American Bar Association, Health Law and Administrative Law and Regulatory Practice Sections
  • International Association of Privacy Professionals
Admissions
  • District of Columbia 2015
  • Illinois 2006
  • Supreme Court of the United States 2010

Vanessa Burrows is Counsel in the Firm’s Corporate Department. Vanessa has advised pharmaceutical and medical device manufacturers, healthcare and technology companies, hospitals and other providers in connection with regulatory and compliance needs, as well as in connection with M&A and capital-raising transactions. Vanessa has extensive experience counseling clients with respect to Health Insurance Portability and Accountability Act (HIPAA) compliance, health privacy, security, and breach issues, fraud and abuse compliance, pharmacy law, cannabis and hemp laws, and public health matters. Vanessa is Counsel in our Washington, D.C. office.

Previously, Vanessa held several government positions focused on healthcare regulation. Her experience includes serving as HIPAA Privacy Officer and Attorney for the Department of Public Health for the City of Chicago. Vanessa also advised Members of Congress and their staff on FDA matters as a Legislative Attorney with the Congressional Research Service.  She handled healthcare law, administrative law and constitutional law matters during the creation and passage of the Patient Protection and Affordable Care Act (ACA).

Experience prior to joining the Firm includes advising:

  • Medical device manufacturers on FDA inspections, warning letters, import alerts and detentions, clinical trial regulations, communications regarding investigational and marketed devices, and product development, labeling and claims
  • Pharmaceutical manufacturers on off-label promotion, codes of conduct, gift and entertainment policies, drug shortages and patient assistance programs
  • Investors, advisors, consultants, hospital and health systems, and manufacturers on FDA, DOJ, DEA, USDA, and state laws, regulations and guidance on hemp, cannabidiol (CBD) and cannabis products
  • A multinational technology company and applicable manufacturers on the Open Payments provisions of the Patient Protection and Affordable Care Act, implementing federal regulations and state transparency and disclosure laws
  • Compounding pharmacies in connection with FDA and state inspections and laws related to dispensing and distribution
  • Clients on anti-kickback, compliance, and scope of practice issues identified in the course of regulatory due diligence
  • Healthcare company and health plan on change of control notices and requirements for state licenses
  • Academic medical centers on federal controlled substances research
  • Health plans, providers, business associates, and subcontractors on breaches, federal and state investigations, audits, risk assessments and requests for information
  • Investors, asset managers, insurers, health plans and providers on HIPAA/Health Information Technology for Economic and Clinical Health Act (HITECH) regulations and guidance related to workforce members, business associate agreements, training, minors, marketing, data use agreements, data security and ransomware
  • Pharmaceutical, medical device, health information technology (HIT) companies on regulatory due diligence

Vanessa received her J.D., cum laude, from American University, Washington College of Law, an M.A., with honors, from Queen’s University Belfast, and a B.A., magna cum laude, from Valparaiso University. She is admitted to practice in the District of Columbia and Illinois.

News & Events

    Publications